10 Best Healthcare Stocks to Buy Under $50

Page 5 of 5

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 77

Share Price: $27.99

Pfizer Inc. (NYSE:PFE) is one of the world’s premier pharmaceutical companies that has been in business since 1849 and sells a wide range of vaccines and drugs globally. After a stellar performance during the first quarter of the year, 77 hedge fund holders remain bullish on the stock, based on Insider Monkey’s database, making it the best healthcare stock to buy under $50.

The company’s operational revenue grew 11% during the quarter (excluding coronavirus treatments), driven by a solid performance from Seagen Inc. – that Pfizer acquired for $43b in December 2023 – and a rise in sales of its already well-established drugs. Moreover, the company also reported an EPS of $0.82, smashing estimates of $0.52 per share. This was the fourth successive quarter during which Pfizer Inc. (NYSE:PFE) had beaten industry estimates.

Pfizer Inc. (NYSE:PFE) has an average 12-month price target of $36.7, with a consensus from analysts from Cantor Fitzgerald (Louise Chen) and BMO Capital (Evan David Seigermen) on its Buy rating.

Overall, Pfizer Inc. (NYSE:PFE) ranks first as the best healthcare stock to buy under $50. You can visit 10 Best Healthcare Stocks to Buy Under $50 to see the other affordable healthcare stocks that are on the hedge fund radar.

While we acknowledge the potential of Pfizer, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than Pfizer but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and Jim Cramer is Recommending These 10 Stocks in June.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5